HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Renato Martins Selected Research
Renato Martins Research Topics
Disease
12
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023 - 07/2005
10
Neoplasms (Cancer)
05/2023 - 06/2010
4
Squamous Cell Carcinoma of Head and Neck
01/2020 - 01/2016
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 01/2016
2
Lung Neoplasms (Lung Cancer)
05/2023 - 01/2019
2
Carcinogenesis
05/2023 - 01/2019
2
Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2021 - 01/2020
1
Mesothelioma
05/2023
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022
1
Chronic Disease (Chronic Diseases)
01/2018
1
Genomic Instability
01/2018
1
Neoplasm Metastasis (Metastasis)
01/2016
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2015
1
Disease Progression
09/2011
1
Pulmonary Atelectasis
02/2011
1
Proteinuria
06/2010
1
Chronic Renal Insufficiency
06/2010
1
Hepatitis
06/2010
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2010
1
Hypertension (High Blood Pressure)
06/2010
Drug/Important Bio-Agent (IBA)
3
Immune Checkpoint Inhibitors
IBA
10/2022 - 01/2019
3
Cisplatin (Platino)
FDA Link
Generic
01/2018 - 09/2009
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
12/2014 - 07/2005
2
ErbB Receptors (EGF Receptor)
IBA
05/2023 - 07/2005
2
Tyrosine Kinase Inhibitors
IBA
01/2021 - 12/2014
2
Biomarkers (Surrogate Marker)
IBA
01/2019 - 09/2011
2
Cetuximab (Erbitux)
FDA Link
01/2017 - 01/2016
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2017 - 09/2011
2
Monoclonal Antibodies
IBA
09/2015 - 06/2010
1
Asbestos
IBA
05/2023
1
Carcinogens
IBA
05/2023
1
Etoposide (VP 16)
FDA Link
Generic
10/2022
1
Platinum
IBA
10/2022
1
130-nm albumin-bound paclitaxel
IBA
01/2021
1
atezolizumab
IBA
01/2020
1
pembrolizumab
IBA
01/2020
1
Vorinostat
FDA Link
01/2020
1
Transcription Factors (Transcription Factor)
IBA
01/2019
1
adavosertib
IBA
01/2018
1
Docetaxel (Taxotere)
FDA Link
01/2018
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2018
1
Gefitinib (Iressa)
FDA Link
12/2014
1
dacomitinib
IBA
12/2014
1
Formaldehyde (Formol)
FDA Link
01/2014
1
Paraffin
IBA
01/2014
1
Nucleotides
IBA
01/2014
1
Ataxia Telangiectasia Mutated Proteins
IBA
06/2012
1
Ligands
IBA
06/2012
1
Carboplatin (JM8)
FDA Link
Generic
09/2011
1
Creatinine
IBA
09/2011
1
Bevacizumab (Avastin)
FDA Link
06/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2010
1
Gemcitabine
FDA Link
09/2009
1
Pemetrexed (MTA)
FDA Link
09/2009
Therapy/Procedure
11
Therapeutics
01/2021 - 09/2011
6
Drug Therapy (Chemotherapy)
10/2022 - 07/2005
3
Radiotherapy
12/2021 - 12/2014
2
Immunotherapy
01/2020 - 01/2017
1
Image-Guided Radiotherapy
01/2020
1
Aftercare (After-Treatment)
01/2018
1
Intermittent Positive-Pressure Breathing
02/2011